Who
Peggie Pelosi
Director
Company insider
Files Form 4 as: Director, USANA Health Sciences; Director, eXp World Holdings.
In numbers
- Trades disclosed
- 119
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $45K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 4 Feb 2019
- Last trade
- 23 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,632 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $20K935 at $20.92 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,632 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,632 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,632 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $20K935 at $20.92 | filing |
| 8 May 2026filed 12 May 2026 | eXp World Holdingsoption or derivative · RE Services & Developers | SEC FORM 4 Code A | —15,152 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | AGNT Agntoption or derivative · RE Services & Developers | SEC FORM 4 Code A | —15,152 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,527 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,527 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,057 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $13K668 at $19.24 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,057 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,057 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,057 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $13K668 at $19.24 | filing |
| 26 Jan 2026filed 27 Jan 2026 | eXp World Holdingsoption or derivative · RE Services & Developers | SEC FORM 4 Code A | —5,258 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | AGNT Agntoption or derivative · RE Services & Developers | SEC FORM 4 Code A | —5,258 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,058 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $15K669 at $22.51 | filing |
News
No headline names them, or the companies they trade most, lately.